T. Rowe Price Associates’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $2.06M | Sell |
|
|||||
|
2024
Q3 | $7.03M | Sell |
|
|||||
|
2024
Q2 | $14.6M | Sell |
|
|||||
|
2024
Q1 | $17.9M | Buy |
|
|||||
|
2023
Q4 | $24.1M | Sell |
|
|||||
|
2023
Q3 | $81.7M | Sell |
|
|||||
|
2023
Q2 | $79M | Sell |
|
|||||
|
2023
Q1 | $115M | Buy |
|
|||||
|
2022
Q4 | $51M | Buy |
|
|||||
|
2022
Q3 | $48.2M | Sell |
|
|||||
|
2022
Q2 | $134M | Buy |
|
|||||
|
2022
Q1 | $146M | Buy |
|
|||||
|
2021
Q4 | $102M | Buy |
|
|||||
|
2021
Q3 | $71.2M | Buy |
|
|||||
|
2021
Q2 | $28.2M | Sell |
|
|||||
|
2021
Q1 | $61.2M | Sell |
|
|||||
|
2020
Q4 | $51.2M | Sell |
|
|||||
|
2020
Q3 | $40.6M | Sell |
|
|||||
|
2020
Q2 | $32.2M | Buy |
|